daunorubicin hydrochloride and cytarabine liposome
(DAW-noh-ROO-bih-sin HY-droh-KLOR-ide … sy-TAYR-uh-been LY-poh-some)
A form of the
anticancer drugs daunorubicin hydrochloride and cytarabine
that is contained inside very tiny, fat-like particles and
is used to treat adults with certain types of newly
diagnosed acute myeloid leukemia.
Daunorubicin hydrochloride and cytarabine liposome may have fewer side
effects and work better than other forms of these drugs. It
is also being studied in the treatment of other types of
cancer. Daunorubicin hydrochloride and cytarabine liposome is a type of
anthracycline antibiotic, a type of topoisomerase
inhibitor, and a type of antimetabolite. Also called Vyxeos.